Literature DB >> 2308133

NMR studies of the conjugation of mechlorethamine with glutathione.

M P Gamcsik1, T G Hamill, M Colvin.   

Abstract

Many cancer cells are resistant to chemotherapeutic treatment with mechlorethamine and other alkylating agents. These drug-resistant cells often show an increase in the intracellular concentration of glutathione and an increase in the activity of glutathione-S-transferase when compared to the sensitive cells. Both of these components are thought to be involved with inactivation of the drug either through conjugation with glutathione or by hydrolysis. NMR spectroscopy was used to monitor the nonenzymatic conjugation of mechlorethamine with glutathione. Several intermediates along the pathway to the doubly glutathione substituted mustard, including both mustard-aziridinium adducts, can be observed. The assignment of the 1H NMR spectrum of these adducts are presented. At 30 degrees C, pH 7.0, no hydrolyzed mustard was detectable. With the use of 13C-labeled mustard, the conjugation reaction can be shown to proceed through an aziridinium intermediate rather than by direct nucleophilic substitution.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2308133     DOI: 10.1021/jm00165a019

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  3 in total

1.  Bifunctional cross-linking approaches for mass spectrometry-based investigation of nucleic acids and protein-nucleic acid assemblies.

Authors:  M Scalabrin; S M Dixit; M M Makshood; C E Krzemien; Daniele Fabris
Journal:  Methods       Date:  2018-05-10       Impact factor: 3.608

2.  Toxic effects of mechlorethamine on mammalian respiratory mucociliary epithelium in primary culture.

Authors:  I Giuliani; E Boivieux-Ulrich; O Houcine; C Guennou; F Marano
Journal:  Cell Biol Toxicol       Date:  1994-08       Impact factor: 6.691

3.  Forced evolution of glutathione S-transferase to create a more efficient drug detoxication enzyme.

Authors:  A M Gulick; W E Fahl
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-29       Impact factor: 11.205

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.